Purchase Order 75N95023P00705
Award Date 8/31/23
Potential Completion Date 8/30/24
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,825 purchase order to Sigma-Aldrich, Inc. for contract 1107546 under contract number 23-005532. Performance will take place in Baltimore, Maryland over the course of one year beginning in September 2023. The firm fixed price contract is for the procurement of products or services to support NIH/NIDA research efforts, though details of the work were not provided....
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $738,065.42 delivery order contract to Axle Informatics, LLC under the Scientific, Operations, and Administrative Resources to the National Institutes of Health indefinite-delivery, indefinite-quantity master contract. The place of performance is Bethesda, Maryland and the period of performance is from December 10, 2021 through June 21, 2026. The contract has a firm fixed price...
- Biomed Services, Inc. has been awarded a $20,330 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to provide biomedical services in support of the agency's research programs. The contract has a one-year period of performance beginning in September 2023, with all work to be conducted by Biomed Services at its Baltimore, Maryland location. No subcontractors or set-aside designations were identified. This award will assist NIH/NIDA in advancing...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Antibodies Incorporated, a small business manufacturer and distributor of antibodies, diagnostics, and laboratory services. The $29,292.00 contract is for the provision of KDEL receptor antibodies, which are used in biomedical research. This award was issued under a total small business set-aside solicitation, and Antibodies...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $559,207.60 firm fixed price delivery order to Axle Informatics, LLC. under the Scientific, Operations, and Administrative Resources to the National Institutes of Health indefinite-delivery/indefinite-quantity master contract vehicle. The delivery order, numbered SOAR-D10 Task Order #119, will be performed in Rockville, Maryland through June 2026 to provide unspecified scientific,...
- Advanced Bioscience Laboratories, Inc., doing business as Advanced Bioscience Laboratories Inc., has been awarded a cost-plus-fixed-fee delivery order contract valued at approximately $1.78 million by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Advanced Bioscience Laboratories will provide cGMP QS21 and produce cGMP ALF55 drug substance in support of the NIH's preclinical development efforts. Work will be performed in Potomac,...
- The National Institute on Drug Abuse (NIDA) awarded a $15.4K firm fixed-price purchase order to Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, for custom conjugation services to support ongoing laboratory studies. The contract, awarded on September 9, 2025, will be performed in Baltimore, Maryland, with an ultimate completion date of September 8, 2026. This procurement was conducted on a full and open basis without small business set-aside...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $94,147.50 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for RNASCOPE HiPlex Mouse RNA Probes. The solicitation was a pre-solicitation notice of intent to award a non-competitive contract under Federal Acquisition Regulation 13.106-1(b) based on only one source being reasonably available. Advanced Cell Diagnostics, Inc. will deliver its RNASCOPE HiPlex Mouse...
- This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to BPS Bioscience Inc., a for-profit Subchapter S Corporation that produces high-quality enzymes, assay kits, and other biological reagents for biomedical research. The $22,600.00 purchase order contract has a firm fixed price and a completion date of August 31, 2019. The award was not set aside for any particular business type. BPS...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $12,199.20 firm fixed price purchase order to EMD Millipore Corporation for MILLI-Q ADVANTAGE A10 water purification systems and associated equipment. EMD Millipore will deliver the systems and parts to support NIH research efforts in Baltimore, Maryland over a one year period of performance from September 2023 through August 2024. As the leading federal funder of substance...
ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH (ABX GMBH) has been awarded a firm fixed-price purchase order contract valued at $20,000 by the National Institutes of Health's National Institute on Drug Abuse. Under this contract, ABX GMBH will provide reagents and synthesis cassettes for F-DOPA to support the NIH's biomedical research efforts. Place of performance will be in Baltimore, Maryland over a one year period from August 2023 through August 2024. No subcontractors or set aside designations were identified. This contract award furthers the NIH's mission to advance the understanding, treatment and prevention of substance abuse and addiction.
Generated 12/22/23, 2:12 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 8/31/23 |